Chi-Ting Huang

Chi-Ting Huang serves as the Vice President of CMC and Process Development. She has over 20 years of experience building and leading CMC and development teams and has contributed to numerous INDs and approved products. Prior to joining Pheon Therapeutics, she held positions at several biotech companies including Surface Oncology, Momenta Pharmaceuticals, Acceleron Pharma, Immunogen Inc., and Genetics Institute/Wyeth Biopharma. Her experience spans a variety of protein-based therapeutic platforms including ADCs, fusion proteins, and soluble proteins. She has earned a Ph.D. in Biochemistry from the University of Minnesota and a B.S. in Chemical Engineering from the University of Illinois.